Caveolin-1 as a Prognostic Marker for Local Control After Preoperative Chemoradiation Therapy in Rectal Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 3, 2009, Pages 846-852

  Rödel, Franz ^a   Capalbo, Gianni ^a   Rödel, Claus ^a   Weiss, Christian ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Caveolin 1; Neoadjuvant chemoradiation therapy; Rectal cancer

Indexed keywords

AMINO ACIDS; BIOPSY; FLUORESCENT SCREENS; PARAMAGNETIC RESONANCE; QUALITY ASSURANCE; TELEVISION PICTURE TUBES; TUMORS;

ADHESION MOLECULES; AFFYMETRIX MICROARRAYS; BIOPSY SAMPLES; CARCINOMA CELLS; CAVEOLAE; CAVEOLIN-1; CELLULAR SIGNAL TRANSDUCTIONS; CHEMORADIATION; CONFIDENCE INTERVALS; EXPRESSION PATTERNS; G-PROTEIN-COUPLED RECEPTORS; IMMUNOHISTOCHEMISTRY; LOCAL CONTROLS; LOCAL FAILURES; MRNA LEVELS; NEOADJUVANT CHEMORADIATION THERAPY; OVER EXPRESSIONS; OVERALL SURVIVAL RATES; OVERALL SURVIVALS; PRE TREATMENTS; PREOPERATIVE CHEMORADIATION; PROTEIN EXPRESSIONS; PROTEIN MARKERS; RECEPTOR TYROSINE KINASE; RECTAL ADENOCARCINOMAS; RECTAL CANCER; SURGICAL RESECTIONS;

SIGNAL TRANSDUCTION;

CAPECITABINE; CAVEOLIN 1; MESSENGER RNA; OXALIPLATIN; TUMOR MARKER;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDICAL RECORD REVIEW; MICROARRAY ANALYSIS; OVERALL SURVIVAL; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECTUM CARCINOMA; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR BIOPSY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAVEOLIN 1; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM PROTEINS; ORGANOPLATINUM COMPOUNDS; PROGNOSIS; PROTEIN ARRAY ANALYSIS; RECTAL NEOPLASMS; REMISSION INDUCTION; RNA, MESSENGER;

EID: 59649124947     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.015     Document Type: Article

References (52)

1. Rödel C., Martus P., Papadoupolos T., et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23 (2005) 8688-8696
2. Rödel C., and Sauer R. Integration of novel agents into combined-modality treatment for rectal cancer patients. Strahlenther Onkol 183 (2007) 227-235
3. Smith F.M., Reynolds J.V., Miller N., et al. Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy. Eur J Surg Oncol 32 (2006) 55-64
4. Ghadimi B.M., Grade M., Difilippantonio M.J., et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 23 (2005) 1826-1838
5. Capalbo G., Rödel C., Stauber R.H., et al. The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target. Strahlenther Onkol 183 (2007) 593-599
6. Rödel C., Grabenbauer G.G., Papadopoulos T., et al. Apoptosis as a cellular predictor for histopathologic response to neoadjuvant radiochemotherapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys 52 (2002) 294-303
7. Razani B., Woodman S.E., and Lisanti M.P. Caveolae: From cell biology to animal physiology. Pharmacol Rev 54 (2002) 431-467
8. Fielding C.J., and Fielding P.E. Caveolae and intracellular trafficking of cholesterol. Adv Drug Deliv Rev 49 (2001) 251-264
9. Liu P., Rudick M., and Anderson R.G. Multiple functions of caveolin-1. J Biol Chem 277 (2002) 41295-41298
10. Shatz M., and Liscovitch M. Caveolin-1: A tumor-promoting role in human cancer. Int J Radiat Biol 84 (2008) 177-189
11. Goetz J.G., Lajoie P., Wiseman S.M., et al. Caveolin-1 in tumor progression: The good, the bad and the ugly. Cancer Metastasis Rev (2008)
12. Williams T.M., and Lisanti M.P. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 288 (2005) C494-C506
13. Galbiati F., Volonte D., Engelman J.A., et al. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J 17 (1998) 6633-6648
14. Bender F.C., Reymond M.A., Bron C., et al. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity. Cancer Res 60 (2000) 5870-5878
15. Wiechen K., Diatchenko L., Agoulnik A., et al. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol 159 (2001) 1635-1643
16. Burgermeister E., Xing X., Rocken C., et al. Differential expression and function of caveolin-1 in human gastric cancer progression. Cancer Res 67 (2007) 8519-8526
17. Yang G., Truong L.D., Wheeler T.M., et al. Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker. Cancer Res 59 (1999) 5719-5723
18. Lavie Y., Fiucci G., and Liscovitch M. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells. J Biol Chem 273 (1998) 32380-32383
19. Campbell L., Jasani B., Edwards K., et al. Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma. Br J Cancer 98 (2008) 931-940
20. Tirado O.M., Mateo-Lozano S., Villar J., et al. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells. Cancer Res 66 (2006) 9937-9947
21. Williams T.M., Hassan G.S., Li J., et al. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: Genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. J Biol Chem 280 (2005) 25134-25145
22. Rödel C., Grabenbauer G.G., Papadopoulos T., et al. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21 (2003) 3098-3104
23. Rödel C., Liersch T., Hermann R.M., et al. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol 25 (2007) 110-117
24. Schlingemann J., Habtemichael N., Ittrich C., et al. Patient-based cross-platform comparison of oligonucleotide microarray expression profiles. Lab Invest 85 (2005) 1024-1039
25. Dworak O., Keilholz L., and Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12 (1997) 19-23
26. Wiechen K., Sers C., Agoulnik A., et al. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol 158 (2001) 833-839
27. Wikman H., Seppanen J.K., Sarhadi V.K., et al. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays. J Pathol 203 (2004) 584-593
28. Wikman H., Kettunen E., Seppanen J.K., et al. Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 21 (2002) 5804-5813
29. Engelman J.A., Zhang X.L., Galbiati F., et al. Chromosomal localization, genomic organization, and developmental expression of the murine caveolin gene family (Cav-1, -2, and -3). Cav-1 and Cav-2 genes map to a known tumor suppressor locus (6-A2/7q31). FEBS Lett 429 (1998) 330-336
30. Hayashi K., Matsuda S., Machida K., et al. Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res 61 (2001) 2361-2364
31. Nasu Y., Timme T.L., Yang G., et al. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. Nat Med 4 (1998) 1062-1064
32. Ando T., Ishiguro H., Kimura M., et al. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Oncol Rep 18 (2007) 601-609
33. Satoh T., Yang G., Egawa S., et al. Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients. Cancer 97 (2003) 1225-1233
34. Kato T., Miyamoto M., Kato K., et al. Difference of caveolin-1 expression pattern in human lung neoplastic tissue. Atypical adenomatous hyperplasia, adenocarcinoma and squamous cell carcinoma. Cancer Lett 214 (2004) 121-128
35. Savage K., Lambros M.B., Robertson D., et al. Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: A morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clin Cancer Res 13 (2007) 90-101
36. Suzuoki M., Miyamoto M., Kato K., et al. Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. Br J Cancer 87 (2002) 1140-1144
37. Yang G., Truong L.D., Timme T.L., et al. Elevated expression of caveolin is associated with prostate and breast cancer. Clin Cancer Res 4 (1998) 1873-1880
38. Fine S.W., Lisanti M.P., Galbiati F., et al. Elevated expression of caveolin-1 in adenocarcinoma of the colon. Am J Clin Pathol 115 (2001) 719-724
39. Patlolla J.M., Swamy M.V., Raju J., et al. Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines. Oncol Rep 11 (2004) 957-963
40. Hung K.F., Lin S.C., Liu C.J., et al. The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis. J Oral Pathol Med 32 (2003) 461-467
41. Joo H.J., Oh D.K., Kim Y.S., et al. Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. Br J Urol Int 93 (2004) 291-296
42. Nestl A., Von Stein O.D., Zatloukal K., et al. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res 61 (2001) 1569-1577
43. Liscovitch M., Burgermeister E., Jain N., et al. Caveolin and cancer: A complex relationship. In: Mattson M.P. (Ed). Membrane microdomain signaling: Lipid rafts in biology and medicine (2005), Humana Press, Totowa, NJ 161-190
44. Zhu H., Cai C., and Chen J. Suppression of P-glycoprotein gene expression in Hs578T/Dox by the overexpression of caveolin-1. FEBS Lett 576 (2004) 369-374
45. Yang C.P., Galbiati F., Volonte D., et al. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells. FEBS Lett 439 (1998) 368-372
46. Belanger M.M., Gaudreau M., Roussel E., et al. Role of caveolin-1 in etoposide resistance development in A549 lung cancer cells. Cancer Biol Ther 3 (2004) 954-959
47. Belanger M.M., Roussel E., and Couet J. Up-regulation of caveolin expression by cytotoxic agents in drug-sensitive cancer cells. Anticancer Drugs 14 (2003) 281-287
48. Ravid D., Maor S., Werner H., et al. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling. Oncogene 24 (2005) 1338-1347
49. Annabi B., Lee Y.T., Martel C., et al. Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (-) epigallocatechin-3-gallate. Cancer Biol Ther 2 (2003) 642-649
50. McLaughlin N., Annabi B., Bouzeghrane M., et al. The survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (-)-epigallocatechin-3-gallate. Brain Res 1071 (2006) 1-9
51. Cordes N., Frick S., Brunner T.B., et al. Human pancreatic tumor cells are sensitized to ionizing radiation by knockdown of caveolin-1. Oncogene 26 (2007) 6851-6862
52. Li J., Hassan G.S., Williams T.M., et al. Loss of caveolin-1 causes the hyper-proliferation of intestinal crypt stem cells, with increased sensitivity to whole body gamma-radiation. Cell Cycle 4 (2005) 1817-1825